652 related articles for article (PubMed ID: 29325547)
1. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.
Ren Y; Jia HH; Xu YQ; Zhou X; Zhao XH; Wang YF; Song X; Zhu ZY; Sun T; Dou Y; Tian WP; Zhao XL; Kang CS; Mei M
Mol Cancer; 2018 Jan; 17(1):5. PubMed ID: 29325547
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R
J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061
[TBL] [Abstract][Full Text] [Related]
4. Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.
Sun L; Wang Y; Wang L; Yao B; Chen T; Li Q; Liu Z; Liu R; Niu Y; Song T; Liu Q; Tu K
J Exp Clin Cancer Res; 2019 Apr; 38(1):170. PubMed ID: 30999932
[TBL] [Abstract][Full Text] [Related]
5. Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma.
Yang J; Lu Y; Lin YY; Zheng ZY; Fang JH; He S; Zhuang SM
Cancer Lett; 2016 Dec; 383(1):18-27. PubMed ID: 27693460
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
7. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
[No Abstract] [Full Text] [Related]
8. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.
You X; Wu J; Zhao X; Jiang X; Tao W; Chen Z; Huang C; Zheng T; Shen X
Aging (Albany NY); 2021 Jul; 13(14):18464-18481. PubMed ID: 34260413
[TBL] [Abstract][Full Text] [Related]
9. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
[TBL] [Abstract][Full Text] [Related]
10. CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.
Tan HX; Xiao ZG; Huang T; Fang ZX; Liu Y; Huang ZC
Cancer Biol Ther; 2020; 21(3):248-257. PubMed ID: 31818187
[No Abstract] [Full Text] [Related]
11. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
12. Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway.
Chandra Jena B; Kanta Das C; Banerjee I; Das S; Bharadwaj D; Majumder R; Mandal M
Biochem Pharmacol; 2021 Apr; 186():114474. PubMed ID: 33607074
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
15. Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment.
Moore-Smith LD; Isayeva T; Lee JH; Frost A; Ponnazhagan S
Sci Rep; 2017 Aug; 7(1):8678. PubMed ID: 28819116
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation.
Jena BC; Das CK; Banerjee I; Bharadwaj D; Majumder R; Das S; Biswas A; Kundu M; Roy PK; Kundu CN; Mandal M
Exp Cell Res; 2022 Aug; 417(1):113195. PubMed ID: 35561786
[TBL] [Abstract][Full Text] [Related]
18. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
19. Autocrine TGF-β1/miR-200s/miR-221/DNMT3B regulatory loop maintains CAF status to fuel breast cancer cell proliferation.
Tang X; Tu G; Yang G; Wang X; Kang L; Yang L; Zeng H; Wan X; Qiao Y; Cui X; Liu M; Hou Y
Cancer Lett; 2019 Jun; 452():79-89. PubMed ID: 30851420
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
